STI Stock Trade Intelligence
NXN

Nexsen Ltd

Health Care · ASX:NXN
$0.1500
▼ -3.23%
Market cap
$14M
Turnover
$1,652
Last price
$0.1500
Day change
-3.23%
Announcements
14
Range, past year
Open 0.165 · Low 0.105 · Now 0.150 · High 0.345
Open NXN in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

NXN momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
32/100
Wyckoff phase
Downtrend2d
Trend stage
Breakdown
1 Day
-3.2%
1 Week
-6.2%
1 Month
+7.1%
1 Year
-11.8%
RSI
45
Avg daily range
5.9%

Nexsen Ltd scores 32 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.

On the Wyckoff cycle it sits in Downtrend, where it has been for 2 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.

Against the wider market it is currently outperforming and the institutional accumulation signal reads low.

Points to watch
  • 60d drawdown -47.7%
  • Thin liquidity
  • Risk rating: Very High
  • Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

NXN announcements

Recent price-sensitive releases.
  • 2026-10-28 Quarterly Report - Q1 FY27 Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
  • 2026-09-25 Proposed FlashDx joint venture builds on CE-marked GBS test Progress Report
  • 2026-09-25 Reinstatement to Quotation Reinstatement to Official Quotation
  • 2026-09-24 Suspension from Quotation Suspension from Official Quotation
  • 2026-09-24 Clear pathway defined to optimise StrepSure Progress Report
  • 2026-09-22 Trading Halt Trading Halt
  • 2026-08-31 Annual Report - FY 2026 Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.